ArticleMolecular oncology2012

Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells.

Anabel Sorolla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.